Ray Dalio 10x Genomics, Inc. Transaction History

Bridgewater Associates, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$24.4 - $41.3 $318,273 - $538,717	13,044 New	13,044 $475,000
Q2 2022 Aug 11, 2022	BUY	$36.95 - $82.41 $92,153 - $205,530	2,494 Added 40.34%	8,676 $393,000
Q1 2022 May 13, 2022	BUY	$55.7 - $145.79 $344,337 - $901,273	6,182 New	6,182 $470,000
Q4 2021 Feb 14, 2022	SELL	$135.05 - $182.59 $268,479 - $362,988	-1,988 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$145.58 - $192.14 $289,413 - $381,974	1,988 New	1,988 $289,000

291

94.7M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.5B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.